Network meta-analysis (NMA) of lenvatinib vs key comparators in first-line unresectable hepatocellular carcinoma (uHCC)

被引：0
|
作者：
Trueman, D. [1 ]
Ndirangu, K. [2 ]
Paine, A. [1 ]
Pilkington, H. [1 ]
机构：
[1] Source Hlth Econ, Hlth Econ & Stat, London, England
[2] Eisai Inc, Global Value & Access, Nutley, NJ USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2151
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1007P
引用
收藏
页码：S615 / S616
页数：2
相关论文
共 50 条
  • [31] NETWORK META-ANALYSIS OF FIRST-LINE SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: WHO IS THE WINNER?
    Celsa, C.
    Cabibbo, G.
    Rizzo, G. E. M.
    Giuffrida, P.
    Di Maria, G.
    Battaglia, S.
    Vaccaro, M.
    Enea, M.
    Giacchetto, C. M.
    Rancatore, G.
    Grassini, M., V
    Ciccia, R.
    Grova, A.
    Salvato, M.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S106 - S106
  • [32] Network Meta-Analysis of Treatments for Unresectable Hepatocellular Carcinoma
    Tremblay, Gabriel
    Meier, Genevieve
    Misurski, Derek
    Baig, Mahadi
    Tamai, Toshiyuki
    Kraljevic, Silvija
    Shor, Anastasiya
    Forsythe, Anna
    HEPATOLOGY, 2017, 66 : 408A - 408A
  • [33] Network meta-analysis of first-line systemic therapies for advanced hepatocellular carcinoma: Who is the winner?
    Celsa, C.
    Cabibbo, G.
    Rizzo, G. E. M.
    Giuffrida, P.
    Enea, M.
    Di Maria, G.
    Antonucci, M.
    Giacchetto, C. M.
    Rancatore, G.
    Grassini, M. V.
    Ciccia, R.
    Grova, A.
    Salvato, M.
    Battaglia, S.
    Vaccaro, M.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S3 - S3
  • [34] A Network Meta-analysis of the Efficacy of Drug Therapy in First-line Treatment of Advanced Hepatocellular Carcinoma
    Wang, Xinchou
    Peng, Gaoyao
    Li, Jiangfa
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2024, 33 (01) : 94 - 101
  • [35] Atezolizumab plus bevacizumab versus lenvatinib as first-line therapy for advanced hepatocellular carcinoma: A systematic review and meta-analysis
    Giri, Suprabhat
    Angadi, Sumaswi
    Vaidya, Arun
    Singh, Ankita
    Roy, Akash
    Sundaram, Sridhar
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 9 (03) : 228 - 235
  • [36] Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis
    Qing Lei
    Xin Yan
    Huimin Zou
    Yixuan Jiang
    Yunfeng Lai
    Carolina Oi Lam Ung
    Hao Hu
    Discover Oncology, 13
  • [37] Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis
    Lei, Qing
    Yan, Xin
    Zou, Huimin
    Jiang, Yixuan
    Lai, Yunfeng
    Ung, Carolina Oi Lam
    Hu, Hao
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [38] NETWORK META-ANALYSIS (NMA) TO ASSESS COMPARATIVE EFFICACY OF LENVATINIB PLUS PEMBROLIZUMAB COMPARED WITH OTHER FIRST-LINE TREATMENTS FOR MANAGEMENT OF ADVANCED RENAL CELL CARCINOMA (ARCC)
    Kadambi, A.
    Pandey, A.
    Neupane, B.
    Fahrbach, K.
    Purushotham, S.
    Jones, M.
    Egodage, S.
    Kashyap, A.
    Pan, J.
    VALUE IN HEALTH, 2022, 25 (07) : S310 - S310
  • [39] Network meta-analysis (NMA) to assess comparative efficacy of lenvatinib plus pembrolizumab compared with other first-line treatments for management of advanced renal cell carcinoma (aRCC).
    Gruenwald, Viktor
    Winquist, Eric
    Peer, Avivit
    Schmidinger, Manuela
    Procopio, Giuseppe
    Barthelemy, Philippe
    Lee, Jae-Lyun
    Rudman, Sarah
    Kadambi, Ananth
    Pandey, Anuja
    Neupane, Binod
    Fahrbach, Kyle
    Purushotham, Sneha
    Jones, Michael
    Egodage, Sonya
    Kashyap, Ananth
    Hauck, Wendy
    Pan, Janice
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 482 - 482
  • [40] Clinical value of atezolizumab plus bevacizumab for first-line unresectable hepatocellular carcinoma (HCC): A network meta-analysis.
    Vogel, Arndt
    Rimassa, Lorenza
    Sun, Hui-Chuan
    Abou-Alfa, Ghassan K.
    El-Khoueiry, Anthony B.
    Pinato, David James
    Daigl, Monica
    Alvarez, Javier Sanchez
    Orfanos, Panos
    Leibfried, Michael
    Zumofen, Marie-Helene Blanchet
    Gaillard, Vincent
    Merle, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345